SIGUIENTE ... : " IDEAYA BIOSCIENCES HA INICIADO UNA COLABORACIÓN CLÍNICA Con ASTRAZENECA " Para Probar el Conjugado Anticuerpo-Fármaco en Fase de Investigación IDE849 , Dirigido Contra la Proteína DLL3 TOP1 , Junto Con el Inhibidor de PD-L1 DURVALUMAB ( IMFINZI de ASTRAZENECA ) , en PACIENTES con SMALL CELL LUNG CANCER EXTENSIVE-STAGE .... ¿ PORQUE NO ELIGIERON AL ATEZOLIZUMAB ... ?
24 julio 2019
STAR MARKET , Brillante Estreno del Nuevo Nasdaq Chino . China's answer to the Nasdaq just started trading. One stock soared 500% .
Hong Kong (CNN Business)China has launched its latest bid for tech superpower status by opening a Nasdaq-style stock market in a frenzy of buying by investors that sent share prices soaring.
Trading on the new tech board of the Shanghai stock exchange, known as the Star Market, began on Monday, less than a year after the initiative was unveiled by President Xi Jinping.
The 25 stocks listed on Star gained 160% on average by midday in China. Shares in Anji Microelectronics Technology, which makes materials for semiconductors, rocketed as much as 520% before trimming those gains a little. ...

